收藏切换
Retrospective analysis of risk factors for coagulation abnormalities in patients with severe infection receiving tigecycline
收藏切换
Ting YANG1, Ake Juma2, Xin ZHANG1, Zuwen MA1, Jing ZHOU1, Pei ZHANG1, *
World Clinical Drug | 2026, 47(5) : 508 - 513
Less
收藏切换
World Clinical Drug | 2026, 47(5): 508-513
• Article •
Retrospective analysis of risk factors for coagulation abnormalities in patients with severe infection receiving tigecycline
Full
Ting YANG1, Ake Juma2, Xin ZHANG1, Zuwen MA1, Jing ZHOU1, Pei ZHANG1, *
Affiliations
  • 1.Department of Pharmacy, The Fifth Affiliated Hospital of Xinjiang Medical University, Urumqi 830011, Xinjiang Uygur Autonomous Region, China
  • 2.Department of Pharmacy, The First People's Hospital of Aksu, Aksu 843000, Xinjiang Uygur Autonomous Region, China
Published: 2026-05-10 doi: 10.13683/j.wph.2026.05.008
Outline
收藏切换
Objective

To analyze changes in coagulation function and risk factors before and after tigecycline administration, so as to promote the rational use and prevent the occurrence of severe adverse reactions.

Methods

Clinical data of 114 severe infection patients who met the inclusion and exclusion criteria and received tigecycline at the Fifth Affiliated Hospital of Xinjiang Medical University from June 2022 to July 2023 were collected. Patients were divided into the normal coagulation group and the coagulation dysfunction group based on coagulation indicators. Univariate and multivariate logistic regression analysis were performed on indicators such as liver and kidney function, blood routine examination, and coagulation function.

Results

At 1—3 days after treatment, patients showed prolonged activated partial thromboplastin time(APTT). At 3—5 days after treatment, patients showed prolonged APTT, prothrombin time(PT),and international normalized ratio, and decreased fibrinogen, with similar results at 5—7 days after treatment. Univariate analysis showed abnormal aspartate aminotransferase and alanine aminotransferase(ALT) were associated with coagulation dysfunction. Multivariate logistic analysis identified abnormal ALT as an independent risk factor(odds ratio=3.92, P<0.05).

Conclusion

Tigecycline may induce coagulation dysfunction in severe infection patients, including prolonged APTT, PT, international normalized ratio and decreased fibrinogen. Liver dysfunction is associated with coagulation disorders, and abnormal ALT may be an independent risk factor.

tigecycline  /  critical infection  /  coagulation  /  risk factors
杨婷, 居马·艾克, 张歆, 马祖文, 周婧, 张裴. 重症感染患者使用替加环素发生凝血异常的危险因素回顾性分析. 世界临床药物, 2026 , 47 (5) : 508 -513 . DOI: 10.13683/j.wph.2026.05.008
Ting YANG, Ake Juma, Xin ZHANG, Zuwen MA, Jing ZHOU, Pei ZHANG. Retrospective analysis of risk factors for coagulation abnormalities in patients with severe infection receiving tigecycline[J]. World Clinical Drug, 2026 , 47 (5) : 508 -513 . DOI: 10.13683/j.wph.2026.05.008
Year 2026 volume 47 Issue 5
54
15
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2026.05.008
  • Receive Date:2025-11-10
  • Online Date:2026-11-05
  • Published:2026-05-10
Article Data
Affiliations
History
  • Received:2025-11-10
  • Revised:2026-04-27
Funding
Affiliations
    1.Department of Pharmacy, The Fifth Affiliated Hospital of Xinjiang Medical University, Urumqi 830011, Xinjiang Uygur Autonomous Region, China
    2.Department of Pharmacy, The First People's Hospital of Aksu, Aksu 843000, Xinjiang Uygur Autonomous Region, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2026.05.008
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT